Enzo Biochem (ENZ) Posts Q4 Adj-Loss of 10c
Tweet Send to a FriendGet Alerts ENZ Hot Sheet
Price: $2.28 +1.33%
EPS Growth %: -250.0%
Financial Fact:
Basic and diluted (in Dollars per share): -0.14
Today's EPS Names:
LBIX, ESEA, ISS, More
EPS Growth %: -250.0%
Financial Fact:
Basic and diluted (in Dollars per share): -0.14
Today's EPS Names:
LBIX, ESEA, ISS, More
Trade ENZ Now!
Enzo Biochem Inc. (NYSE: ENZ) reports Q4 adj-loss of $0.10, 1 cent lower than the analyst estimate of ($0.09). Revenue for the quarter was $24.9 million, which compares to the estimate of $24.58 million.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- UPDATE: Applied Materials, Inc. (AMAT) Tops Q2 EPS by 3c, Offers Guidance
- Notable Winners and Losers from Q1 Earnings Season: (YRCW) (TSLA) (AVEO) (CRMB)
- 21Vianet Group (VNET) Misses Q1 EPS by 4c
Create E-mail Alert Related Categories
Earnings
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
